MDL 105519
MDL 105519 is a potent and selective antagonist of glycine binding to the NMDA receptor.
Product Specifications
CAS Number
161230-88-2
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/MDL-105519.html
Concentration
10mM
Purity
99.67
Solubility
DMSO : 17 mg/mL (ultrasonic; warming)
Smiles
O=C(O)C(N1)=C(/C=C(C2=CC=CC=C2)/C(O)=O)C3=C1C=C(Cl)C=C3Cl
Molecular Formula
C18H11Cl2NO4
Molecular Weight
376.19
References & Citations
[1]Baron BM, et al. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. Eur J Pharmacol. 1997 Apr 4;323 (2-3) :181-92.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NMDA Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY418898 100 µg
SOAT 1 (SOAT1) (NM_003101) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC882967-100 1x 100 µL
HLA-Pan (MHC II) (HLA-Pan/2967R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
